The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

INTRODUCTION: In immunocompromised patients, acute respiratory failure (ARF) is associated with high mortality, particularly when invasive mechanical ventilation (IMV) is required. In patients with severe hypoxemia, high-flow nasal oxygen (HFNO) therapy has been used as an alternative to delivery of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemiale, Virginie, Mokart, Djamel, Mayaux, Julien, Lambert, Jérôme, Rabbat, Antoine, Demoule, Alexandre, Azoulay, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629403/
https://www.ncbi.nlm.nih.gov/pubmed/26521922
http://dx.doi.org/10.1186/s13054-015-1097-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629403/
https://www.ncbi.nlm.nih.gov/pubmed/26521922
http://dx.doi.org/10.1186/s13054-015-1097-0

Ejemplares similares